Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 10,000 shares at $0.69 ($7K) on 2017-01-19, disclosed to the SEC on 2017-01-19.
Open-market purchase of $7k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 600 | $414 | 5.9% |
| 2 | $0.69 | 3,000 | $2K | 29.7% |
| 3 | $0.70 | 6,400 | $4K | 64.3% |
| Total | $0.70 avg | 10,000 | $7K | 100% |
| Filing → |
| RXII | BUY | 2017-06-22 | $6K | — | Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |